4.3 Article

Gene Therapy for Rhodopsin Mutations

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis

Callie Deng et al.

Summary: This study investigates the safety and efficacy of voretigene neparvovec gene therapy in pediatric patients with biallelic RPE65 disease-causing variants. Results show significant improvements in visual function and retinal structure, including improved visual field and visual acuity, as well as small but statistically significant changes in central subfield thickness. Postoperative complications were generally manageable and resolved over time.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)

Article Biotechnology & Applied Microbiology

A Modified Arrestin1 Increases Lactate Production in the Retina and Slows Retinal Degeneration

Tiffany S. Nelson et al.

Summary: Glucose metabolism in the retina is carefully regulated, with glucose being delivered to photoreceptors from the choroidal circulation. This study investigates the use of a modified protein called ArrGG to increase lactate production and slow down retinal degeneration. Overexpression of ArrGG in mouse retinas resulted in an increase in lactate secretion, while in a mouse model of retinitis pigmentosa, the expression of ArrGG led to significant preservation of photoreceptor function and slowing of retinal degeneration. These findings suggest that enhancing glycolysis may offer a therapeutic approach to slow down retinal degeneration.

HUMAN GENE THERAPY (2022)

Article Biotechnology & Applied Microbiology

CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa

Wen-Hsuan Wu et al.

Summary: This study presents a CRISPR-based gene modification therapy for autosomal dominant retinitis pigmentosa, which has been validated in a humanized mouse model, demonstrating the effectiveness of the treatment and its potential application in other genetic diseases.

MOLECULAR THERAPY (2022)

Review Ophthalmology

Early and late stage gene therapy interventions for inherited retinal degenerations

Catherine Botto et al.

Summary: Inherited and age-related retinal degeneration are major causes of untreatable blindness. Genetic factors play a significant role in these diseases, and gene therapy is rapidly becoming a viable treatment approach. This article provides an overview of retinal gene therapy methods and their relevance to patients with inherited retinal degenerations.

PROGRESS IN RETINAL AND EYE RESEARCH (2022)

Review Genetics & Heredity

Gene-Based Therapeutics for Inherited Retinal Diseases

Beau J. Fenner et al.

Summary: In this review, the application of gene therapy in inherited retinal diseases (IRDs) is discussed. Following the approval of an IRD gene replacement therapy for Leber's congenital amaurosis, clinical trials for various IRDs are underway. The review emphasizes on five different gene therapy approaches, including gene replacement, genome editing, RNA editing, mRNA targeting, and optogenetic approaches, that have the potential to treat the full spectrum of IRDs.

FRONTIERS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing

Jessica D. Gumerson et al.

Summary: The study successfully restored the RPGR(ORF15) gene mutation in the rd9 mouse model using CRISPR/Cas9 gene editing technology, correcting the function of the Retinitis Pigmentosa GTPase Regulator and eliminating early disease phenotypes associated with the mutation.

GENE THERAPY (2022)

Article Ophthalmology

Visual Acuity, Retinal Morphology, and Patients' Perceptions after Voretigene Neparovec-rzyl Therapy for RPE65-Associated Retinal Disease

Jesse D. Sengillo et al.

Summary: This study aimed to investigate the impact of patients' age, baseline visual acuity, and intraoperative foveal detachment on the outcomes of subretinal voretigene neparvovec-rzyl therapy, as well as the patients' perceptions of the treatment effect. The results showed that there were no significant vision changes for adult patients, while there was a trend of improvement for pediatric patients. The decrease in foveal thickness was observed, but its long-term significance remains to be determined.

OPHTHALMOLOGY RETINA (2022)

Review Ophthalmology

Immune responses to retinal gene therapy using adeno-associated viral vectors-Implications for treatment success and safety

Kirsten Bucher et al.

Summary: Recombinant adeno-associated virus (AAV) is a leading vector for gene therapy in the retina, efficiently transducing retinal cells but also causing intraocular inflammation and immune responses. The eye, being an immune-privileged site, may mitigate these responses, but further research is needed to understand influencing factors.

PROGRESS IN RETINAL AND EYE RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes

Sook Hyun Chung et al.

Summary: Suprachoroidal space offers a novel route for ocular drug delivery and has potential significance for gene therapy. Research shows that suprachoroidal AAV8 primarily triggers host immune responses against GFP, but elicits less humoral immune reactivity to the viral capsid, suggesting significant translational potential for human transgenes in retinal gene therapy.

HUMAN GENE THERAPY (2021)

Article Developmental Biology

Human retinal model systems: Strengths, weaknesses, and future directions

Kiara C. Eldred et al.

Summary: The human retina has unique features that make it an ideal model for studying neuronal cell fate specification. Recent advances in culturing retinal tissue have provided new insights and moved us closer to developing regenerative therapies for vision loss. Different human retinal model systems, including dissociated primary tissue, explanted primary tissue, retinospheres, and stem cell-derived retinal organoids, have strengths, weaknesses, and potential for future research directions.

DEVELOPMENTAL BIOLOGY (2021)

Article Genetics & Heredity

Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model

Clarissa Patrizi et al.

Summary: RP is a progressive retinal degenerative disease causing blindness, and CRISPR/Cas9 can selectively target specific variants for gene editing to restore partial retinal function.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Cell Biology

Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses

Ying Kai Chan et al.

Summary: The study engineered AAV vectors by incorporating short DNA oligonucleotides to antagonize TLR9 activation, reducing innate immune responses and enhancing gene expression in clinically relevant animal models. The engineered vectors can avoid adverse reactions in some models, demonstrating a potential wider therapeutic window for AAV therapies.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Biology

Photoreceptor metabolic reprogramming: current understanding and therapeutic implications

Warren W. Pan et al.

Summary: Photoreceptor death is central to vision loss in various retinal diseases. Disruption of nutrient availability and cell metabolism may underlie photoreceptor death. In this review, Pan et al. focus on the recent advances in the understanding of photoreceptor metabolism and suggest novel targets for neuroprotective strategies that prevent blindness.

COMMUNICATIONS BIOLOGY (2021)

Article Medicine, Research & Experimental

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders

Marina Pavlou et al.

Summary: A novel engineered rAAV vectors have been developed for efficient targeting of photoreceptors via less invasive intravitreal administration, showing potential for clinical application in treating blinding retinal dystrophies.

EMBO MOLECULAR MEDICINE (2021)

Article Ophthalmology

Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease Phase 3 Results at 3 and 4 Years

Albert M. Maguire et al.

Summary: The study found that improvements in functional vision and visual function after VN treatment in patients with biallelic RPE65 mutation-associated inherited retinal disease can be maintained for 3 to 4 years with good safety outcomes. Specifically, improvements in ambulatory navigation, light sensitivity, and visual field were consistent in both intervention groups and the safety profile of VN was similar between groups, with no serious adverse events reported.

OPHTHALMOLOGY (2021)

Article Biology

AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa

Yunlu Xue et al.

Summary: Research has found that an adeno-associated virus vector expressing the Txnip gene can prolong the survival of cone photoreceptors and improve vision in RP mouse models. Additionally, a Txnip allele called C247S offers even greater benefits, and the rescue effect of Txnip relies on lactate dehydrogenase b (Ldhb).

ELIFE (2021)

Article Biochemistry & Molecular Biology

Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis

Elena Marrocco et al.

Summary: The synthetic transcriptional repressor ZF6-DB designed for treating retinitis pigmentosa does not disrupt murine retinal development while effectively blocking target gene expression. Delivery of ZF6-DB during retinal development in mice results in morphological and functional recovery of the retina in a model of retinitis pigmentosa. The study suggests the use of developmental transitions as a safe approach for retinal gene therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases

Moritz J. Schmidt et al.

Summary: Researchers characterize four small nucleases and use protein engineering to create effective in vivo editors with high editing efficiency and specificity.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa

Harry O. Orlans et al.

Summary: The study developed a novel gene knockdown/replacement therapy based on mirtrons, demonstrating that synthetic mirtrons delivered by AAV are capable of reducing disease severity in vivo.

NATURE COMMUNICATIONS (2021)

Review Biotechnology & Applied Microbiology

Prime Editing for Inherited Retinal Diseases

Bruna Lopes da Costa et al.

Summary: Inherited retinal diseases (IRDs) are chronic, hereditary disorders that lead to progressive degeneration of the retina. While there is currently only one FDA-approved gene augmentation therapy available, new techniques such as prime editing (PE) offer promising implications for the future of IRD treatment.

FRONTIERS IN GENOME EDITING (2021)

Review Biotechnology & Applied Microbiology

Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision Loss

Catherine Botto et al.

Summary: Blindness and deafness, two common sensory disorders in humans, are often linked to irreversible damage to photoreceptor cells and hair cells. Gene replacement therapies and silencing approaches have shown promising results in treating rare genetic disorders of the retina and deafness, offering new possibilities for therapeutic applications. New DNA- and RNA-based CRISPR/Cas nucleases are providing opportunities for directly repairing mutations and restoring gene function, highlighting the potential for successful therapeutic application in vivo.

FRONTIERS IN GENOME EDITING (2021)

Article Ophthalmology

Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice

Gayathri Tummala et al.

Summary: The intravitreal injection of AAV in mice results in mild clinically evident inflammation that tends to resolve spontaneously. However, the total number of intraocular CD45+ cells, particularly T cells, remains elevated. Both innate and adaptive immune cells respond to intravitreal AAV regardless of prior immune status, but the adaptive response is delayed in AAV naive eyes.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Article Medicine, General & Internal

Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration

Katherine J. Wert et al.

EBIOMEDICINE (2020)

Article Medicine, Research & Experimental

AAV-miR-204 Protects from Retinal Degeneration by Attenuation of Microglia Activation and Photoreceptor Cell Death

Marianthi Karali et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Medicine, Research & Experimental

Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates

Glenn Yiu et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Biotechnology & Applied Microbiology

Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy

Sanford L. Boye et al.

MOLECULAR THERAPY (2020)

Article Medicine, Research & Experimental

In vivo directed evolution of adeno-associated virus in the primate retina

Leah C. Byrne et al.

JCI INSIGHT (2020)

Article Biochemistry & Molecular Biology

Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution

Cameron S. Cowan et al.

Article Medicine, General & Internal

SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS

Christian Mueller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Biochemistry & Molecular Biology

The Rise of Retinal Organoids for Vision Research

Kritika Sharma et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Genetics & Heredity

Retinal miRNA Functions in Health and Disease

Marta Zuzic et al.

GENES (2019)

Article Multidisciplinary Sciences

Search-and-replace genome editing without double-strand breaks or donor DNA

Andrew V. Anzalone et al.

NATURE (2019)

Article Biotechnology & Applied Microbiology

Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque

K. Tyler McCullough et al.

HUMAN GENE THERAPY (2019)

Review Biochemistry & Molecular Biology

Metazoan MicroRNAs

David P. Bartel

Article Ophthalmology

The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy

Dimitra Athanasiou et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2018)

Article Multidisciplinary Sciences

Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector

Artur V. Cideciyan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Stimulation of AMPK prevents degeneration of photoreceptors and the retinal pigment epithelium

Lei Xu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Ophthalmology

Expression Profiling Analysis Reveals Key MicroRNA-mRNA Interactions in Early Retinal Degeneration in Retinitis Pigmentosa

Ander Anasagasti et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)

Review Biotechnology & Applied Microbiology

Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina

Pavitra S. Ramachandran et al.

HUMAN GENE THERAPY (2017)

Article Biochemistry & Molecular Biology

The role of the ER stress-response protein PERK in rhodopsin retinitis pigmentosa

Dimitra Athanasiou et al.

HUMAN MOLECULAR GENETICS (2017)

Article Multidisciplinary Sciences

MiR-211 is essential for adult cone photoreceptor maintenance and visual function

Sara Barbato et al.

SCIENTIFIC REPORTS (2017)

Article Biochemistry & Molecular Biology

Phototransduction Influences Metabolic Flux and Nucleotide Metabolism in Mouse Retina

Jianhai Du et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Medicine, Research & Experimental

Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration

Lijuan Zhang et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Multidisciplinary Sciences

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Alexis C. Komor et al.

NATURE (2016)

Article Biology

Rhodopsin targeted transcriptional silencing by DNA-binding

Salvatore Botta et al.

eLife (2016)

Article Biochemistry & Molecular Biology

Rod-Derived Cone Viability Factor Promotes Cone Survival by Stimulating Aerobic Glycolysis

Najate Ait-Ali et al.

Article Biochemistry & Molecular Biology

Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype

Zongchao Han et al.

FASEB JOURNAL (2015)

Article Ophthalmology

Retinal histopathology in eyes from patients with autosomal dominant retinitis pigmentosa caused by rhodopsin mutations

Vera L. Bonilha et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)

Review Neurosciences

Glucose, lactate, and shuttling of metabolites in vertebrate retinas

James B. Hurley et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2015)

Article Multidisciplinary Sciences

MiR-204 is responsible for inherited retinal dystrophy associated with ocular coloboma

Ivan Conte et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Medicine, Research & Experimental

Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration

Leah C. Byrne et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Neurosciences

Robust Endoplasmic Reticulum-Associated Degradation of Rhodopsin Precedes Retinal Degeneration

Wei-Chieh Chiang et al.

MOLECULAR NEUROBIOLOGY (2015)

Article Medicine, Research & Experimental

Genes and Mutations Causing Autosomal Dominant Retinitis Pigmentosa

Stephen P. Daiger et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

Article Ophthalmology

Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration

Susan F. Murray et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Article Ophthalmology

Targeting Caspase-12 to Preserve Vision in Mice With Inherited Retinal Degeneration

Yogesh Bhootada et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Review Biotechnology & Applied Microbiology

Recombinant AAV as a Platform for Translating the Therapeutic Potential of RNA Interference

Florie Borel et al.

MOLECULAR THERAPY (2014)

Article Ophthalmology

Vector platforms for gene therapy of inherited retinopathies

Ivana Trapani et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2014)

Article Ophthalmology

A Pro23His Mutation Alters Prenatal Rod Photoreceptor Morphology in a Transgenic Swine Model of Retinitis Pigmentosa

Patrick A. Scott et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)

Article Ophthalmology

Cone Photoreceptors Develop Normally in the Absence of Functional Rod Photoreceptors in a Transgenic Swine Model of Retinitis Pigmentosa

Juan P. Fernandez de Castro et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)

Review Respiratory System

Gene-Based Therapy for Alpha-1 Antitrypsin Deficiency

Christian Mueller et al.

COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)

Article Biochemistry & Molecular Biology

Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa

D. L. Greenwald et al.

GENE THERAPY (2013)

Review Biotechnology & Applied Microbiology

A Comprehensive Review of Retinal Gene Therapy

Shannon E. Boye et al.

MOLECULAR THERAPY (2013)

Article Biochemistry & Molecular Biology

siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouse

Ryan L. Boudreau et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Multidisciplinary Sciences

Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors

Christine N. Kay et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

RNA-Guided Human Genome Engineering via Cas9

Prashant Mali et al.

SCIENCE (2013)

Review Biochemistry & Molecular Biology

Novel adeno-associated viral vectors for retinal gene therapy

L. H. Vandenberghe et al.

GENE THERAPY (2012)

Article Multidisciplinary Sciences

ER Stress in Retinal Degeneration in S334ter Rho Rats

Vishal M. Shinde et al.

PLOS ONE (2012)

Article Ophthalmology

Generation of an Inbred Miniature Pig Model of Retinitis Pigmentosa

Jason W. Ross et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)

Article Ophthalmology

ER Stress Is Involved in T17M Rhodopsin-Induced Retinal Degeneration

Mansi M. Kunte et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)

Article Medicine, Research & Experimental

Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa

Claudio Mussolino et al.

EMBO MOLECULAR MEDICINE (2011)

Article Biotechnology & Applied Microbiology

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Sophia Millington-Ward et al.

MOLECULAR THERAPY (2011)

Article Biotechnology & Applied Microbiology

AAV Mediated GDNF Secretion From Retinal Glia Slows Down Retinal Degeneration in a Rat Model of Retinitis Pigmentosa

Deniz Dalkara et al.

MOLECULAR THERAPY (2011)

Article Biotechnology & Applied Microbiology

Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina

Hilda Petrs-Silva et al.

MOLECULAR THERAPY (2011)

Review Multidisciplinary Sciences

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

Peter Walter et al.

SCIENCE (2011)

Review Pharmacology & Pharmacy

RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

C. Frank Bennett et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)

Article Multidisciplinary Sciences

Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78

Marina. S. Gorbatyuk et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Pharmacology & Pharmacy

Small silencing RNAs: State-of-the-art

Dirk Grimm

ADVANCED DRUG DELIVERY REVIEWS (2009)

Article Biotechnology & Applied Microbiology

Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy

Naomi Chadderton et al.

MOLECULAR THERAPY (2009)

Article Biotechnology & Applied Microbiology

High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors

Hilda Petrs-Silva et al.

MOLECULAR THERAPY (2009)

Article Biochemistry & Molecular Biology

ATP Consumption by Mammalian Rod Photoreceptors in Darkness and in Light

Haruhisa Okawa et al.

CURRENT BIOLOGY (2008)

Article Ophthalmology

A common microRNA signature in mouse models of retinal degeneration

Carol J. Loscher et al.

EXPERIMENTAL EYE RESEARCH (2008)

Article Multidisciplinary Sciences

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

Jodi L. McBride et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs

Ryan L. Boudreau et al.

Article Ophthalmology

Retinal Laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations

Tomas S. Aleman et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)

Article Multidisciplinary Sciences

IRE1 signaling affects cell fate during the unfolded protein response

Jonathan H. Lin et al.

SCIENCE (2007)

Review Cell Biology

Signal integration in the endoplasmic reticulum unfolded protein response

David Ron et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Biochemical Research Methods

A protocol for designing siRNAs with high functionality and specificity

Amanda Birmingham et al.

NATURE PROTOCOLS (2007)

Article Biochemistry & Molecular Biology

GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells

SM Hauck et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Biochemical Research Methods

3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets

A Birmingham et al.

NATURE METHODS (2006)

Article Ophthalmology

Long-term safety of GDNF gene delivery in the retina

WC Wu et al.

CURRENT EYE RESEARCH (2005)

Article Multidisciplinary Sciences

In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa

AV Cideciyan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Biochemistry & Molecular Biology

Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy

HF Mendes et al.

TRENDS IN MOLECULAR MEDICINE (2005)

Article Biochemistry & Molecular Biology

The G protein-coupled receptor rhodopsin in the native membrane

D Fotiadis et al.

FEBS LETTERS (2004)

Article Biotechnology & Applied Microbiology

Rational siRNA design for RNA interference

A Reynolds et al.

NATURE BIOTECHNOLOGY (2004)

Article Genetics & Heredity

Identification and characterization of rod-derived cone viability factor

T Léveillard et al.

NATURE GENETICS (2004)

Article Biochemistry & Molecular Biology

The supramolecular structure of the GPCR rhodopsin in solution and native disc membranes

K Suda et al.

MOLECULAR MEMBRANE BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Intracellular ribozyme applications

D Castanotto et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2002)

Article Multidisciplinary Sciences

Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa

JW Kijas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Biochemistry & Molecular Biology

Validated zinc finger protein designs for all 16 GNN DNA triplet targets

Q Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Multidisciplinary Sciences

Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy

MM LaVail et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)